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Abstract  
 
Chronic post-surgical pain (CPSP) is a well-recognized potential complication with negative 
personal, social and healthcare consequences. However, limited data exists on CPSP and 
on the course of pain over time after hysterectomy. Using data from a prospective cohort 
study on a consecutive sample assessed at 4 time points, pre-surgery (T1), 48 hours (T2), 4 
months (T3), and 5 years post-surgery (T4), we sought to examine women’s post-surgical 
pain trajectories using assessments of pain at T3 and T4. Additionally, this study aimed to 
investigate pre-surgical and post-surgical risk factors associated with an unfavourable pain 
trajectory (PT). Based on pain data collected at T3 and T4, three distinct trajectories of 
post-surgical pain (PSP) emerged: no CPSP (PT1;n=88), prolonged PSP (PT2;n=53) and CPSP 
(PT3;n=29). Moreover, reported CPSP prevalence at 5 years was 17.1%. Multinomial 
logistic regression models controlling for age, pre-surgical pain and type of hysterectomy 
tested for baseline and acute post-surgical predictive variables. Membership in PT2 and 
PT3 was predicted by pre-surgical anxiety (OR=1.131, p=0.015; OR=1.175, p=0.009, 
respectively), emotional representation of the surgical disease (OR=1.155, p=0.034; 
OR=1.213, p=0.020, respectively) and pain catastrophizing (OR=1.079, p=0.043; OR=1.143, 
p=0.001, respectively). Furthermore, acute post-surgical pain intensity and frequency 
determined membership of women in PT3 (OR=1.211, p=0.033; OR=3.000, p=0.029, 
respectively), and post-surgical anxiety (OR=1.182, p=0.026) also played a key predictive 
role. This study identified factors that can be easily screened before and after surgery, and 
are amenable to change through carefully designed timely and tailored interventions for 
women at risk of an unfavorable post-surgical pain trajectory post-hysterectomy.  
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1. INTRODUCTION 
 
Chronic pain after surgery is a well-recognized potential complication, being 
acknowledged as a major clinical problem with significant individual, social and healthcare 
costs 52,56, 60. It is a serious public health issue, since surgeries are widely performed, 
increasing the numbers of those at risk [13,49,56]. Indeed, the current version of the 
International Classification of Diseases (ICD-11) for chronic pain categorization already 
proposes chronic post-surgical pain (CPSP) as a new distinct entity among seven groups of 
chronic pain disorders [103].  
CPSP was first mentioned in 1998 [26], being highlighted that 22.5% of patients attending 
10 pain clinics pointed surgery as the cause for chronic pain. Despite improvements in 
knowledge regarding epidemiology and CPSP burden, its underlying mechanisms are not 
fully understood [48,105]. However, evidence suggests that CPSP development is 
multifactorial, rooted in a dynamic and complex interplay amongst biological, psychosocial 
and environmental factors [23,49]. To increase knowledge, research has focused 
increasingly on understanding risk factors, in hopes of finding new ways to treat and 
ultimately prevent CPSP from occurring.  
Risk factors are often conceptualized into pre-surgical, intra-surgical and post-surgical, 
embracing variables such as age, surgery type, previous pain and acute post-surgical pain 
[52,53,60,63,74]. Psychological factors are well-documented predictors for CPSP across 
different surgeries [2,15,41,44,62,77], including anxiety [59,62,100], depression 110, 
pain catastrophizing [28,51,57,59,100] and optimism [40,83]. In an attempt to systematize 
information, VanDenKerkhof et al [105] proposed a framework wherein risk factors are 
organized into five domains: demographic, pain, clinical, surgery-related, and 
psychological. 
Hysterectomy is the most common gynecologic surgery performed in women in Western 
countries [86,99]. In a review including 11 hysterectomy studies, with follow-up times up 
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to 2 years, CPSP was reported by 5-32% of women [8]. Subsequent studies kept diverging 
on prevalence rates. These differences were likely due to distinct CPSP definitions, 
heterogeneity of measurement and differences in follow-up times; some were 3 [101], 4 
[6,68,80], 6 months [81,104], 1 [7,68,101] or 2 years [68]. Simultaneously, risk factors that 
have been most highlighted were age [68,80], pre-surgical pain [7,68,101,104], other pain 
problems [6,7,68,80] and psychological factors [68,80,101,104]. Within the latter, there 
was some heterogeneity due to different measures used. Furthermore, acute post-surgical 
pain intensity was more strongly related with CPSP in some hysterectomy studies 
[6,101,104] than in others [68,80], with one of the studies proposing post-surgical pain 
frequency as a better predictor than intensity [80].  
Whilst the incidence and risk factors for CPSP have been widely explored, knowledge on 
the course of post-surgical pain over time is limited. Identifying patients who are at risk of 
an unfavorable pain trajectory, culminating in CPSP, provides a unique opportunity to 
investigate the transition from acute to chronic pain and is critical to developing a more 
comprehensive understanding of CPSP and establishing potential targets for psychosocial 
and clinical interventions.  
Therefore, the aims of this study were: (1) to examine post-surgical pain trajectory up to 5 
years after hysterectomy; (2) to investigate baseline predictors of different pain 
trajectories; and (3) to further explore the added predictive value of acute post-surgical 
factors in pain chronification. 
 
2. METHODS 
 
2.1. Participants and Procedure 
This study was conducted in a central hospital in northern Portugal and approval was 
granted by the Hospital Ethics Committee. This was a prospective cohort study with 
longitudinal assessments at 4 time points: 24 hours before surgery (T1), 48 hours (T2), 4 
months (T3) and 5 years (T4) after surgery. Assessments were performed between March 
2009 and January 2015. A consecutive sample of 203 women, undergoing hysterectomy 
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due to benign causes, was invited to participate in the study and all provided written 
informed consent. Inclusion criteria were age between 18 and 80 years, and the ability to 
understand consent procedures and questionnaire materials. Exclusion criteria were the 
presence of psychiatric or neurologic pathology (e.g. dementia) and undergoing 
hysterectomy due to malign conditions or in emergency setting. Time 1 and T2 
assessments took place in hospital, T3 and T4 follow-up assessment were conducted by 
telephone interview. Inclusion in each assessment point and the reasons for loss to T2, T3 
and T4 are shown in a flowchart (Figure 1). The final sample is comprised of 170 women 
(retention rate: 83.7%; age: M=50.8; SD=9.03; minimum=35; maximum=76) with 
assessments performed at T1, T2, T3 and T4. The 33 women lost to follow-up, from T1 to 
T4, did not differ significantly from the women evaluated over 5 years in terms of baseline 
demographic, psychological and clinical characteristics, namely on surgical, anesthetic and 
analgesic issues.  
Data related to this sample have been described in four previous publications reporting 
predictors of acute post-surgical pain [76,77], predictors of rescue analgesia 
administration [79] and predictors of persistent post-surgical pain 4 months after 
hysterectomy [80]. The present work is the first to report the long-term outcomes in this 
sample, 5 years post-hysterectomy, including the four assessment points. 
 
 
2.2. Data Collection 
 
2.2.1. Pre-surgical assessment – 24 hours before surgery (T1) 
At hospital admission, and in order to get a baseline evaluation of women, the Portuguese 
versions of the following questionnaires were administered, in a face to face interview, by 
a trained health psychologist. 
2.2.1.1. Socio-Demographic Questionnaire: included questions on age, height, weight, 
education, residence, marital status, professional status, household and parity. 
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2.2.1.2. Clinical Questionnaire: enquired about previous pain, either related to the cause 
of surgery or due to other causes, previous surgeries, menopause status, 
diagnosis/indication for hysterectomy and disease onset, uterus height and weight, as well 
as the use of psychotropic drugs (anxiolytics and anti-depressants). 
2.2.1.3. The Brief Pain Inventory – short form (BPI-SF) [24]: employed among women 
reporting pre-surgical pain (related with the disease underlying the surgery). It measured: 
pain location in the body; pain intensity on an 11-point numerical rating scale (NRS; 0 
represents “no pain” and 10 the “worst pain imaginable”); analgesic intake; perception of 
analgesic relief; and pain interference with daily life on an 11-point NRS (0 = “does not 
interfere” and 10 = “completely interferes”) in distinct dimensions (general activity, mood, 
walking, work, relations with others, sleep and enjoyment of life). Higher scores represent 
higher levels of pain interference. In this study, the internal consistency reliability [27] for 
the pain interference subscale scores was high (α = 0.90). 
2.2.1.4. The Hospital Anxiety and Depression Scale (HADS) [112]: comprised by two 
subscales used to measure anxiety and depression via 7 items each. Subscale scores range 
from 0 to 21 and result from the sum of each item (Likert scale ranging from 0 to 3). 
Higher scores correspond to higher levels of anxiety and depression. In the current 
sample, internal consistency reliability was adequate for both anxiety T1: α = 0.77; T2: α = 
0.84) and depression (T1: α = 0.81).  
2.2.1.5. The Surgical Fear Questionnaire (SFQ) [102]: used to evaluate specific surgical 
fears via 8 items aggregated in 2 subscales, “fear of immediate consequences of surgery” 
(α = 0.77; 4 items) and “fear of long-term consequences of surgery” (α = 0.75; 4 items). 
Each item score ranges from 0 to 10; item scores are summed to calculate each total 
subscale score. Subscale scores range between 0 and 40, with higher values indicating 
higher levels of fear.  
2.2.1.6. The Revised Illness Perception Questionnaire (IPQ-R) [69]: employed to assess 
patient beliefs about the underlying disease that lead to surgery, is comprised by seven 
dimensions. In the current study, and with the aim of diminishing participant burden, a 
psychometrically shortened version [78,80] was used, with 3 items composing each one of 
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the 7 subscales: “timeline acute/chronic” (α=0.79; e.g. “My illness will last for a long 
time”); “timeline cyclical” (α=0.74; e.g., “My symptoms come and go in cycles”); 
“consequences” (α=0.56; e.g., “The disease underlying surgery has major consequences 
on my life”); “personal control” (α=0.53; e.g., “I have the power to influence my illness”); 
“treatment control” (α=0.76; e.g., “Surgery can control my illness”); “illness coherence” 
(α=0.78; e.g., “My illness is a mystery for me”); “emotional representation” (α=0.88; e.g., 
“When I think about my illness I get upset”). “Consequences” and “personal control” were 
not included due to their low score reliability in this sample (α=0.56 and α=0.53, 
respectively). Each item is rated on a scale of 1-5 and to calculate each total subscale 
score, items are summed. Each subscale varies between 5 and 15, with high scores 
revealing less adaptive illness perceptions, with the exception of personal and treatment 
control subscales, which score inversely.  
 
2.2.1.7. The Coping Strategies Questionnaire – Revised Form (CSQ-R) [88]: used to 
evaluate six pain coping strategies: pain catastrophizing” (5 items; α=0.88); “praying and 
hoping” (3 items; α=0.88); “ignoring pain” (5 items; α=0.92); “distraction/diverting 
attention” (5 items; α=0.77); “reinterpreting pain” (4 items; α=0.74); and “pain coping 
self-statements” (4 items; α=0.70). During pilot testing, subjects were often confused by 
the usual 7-point Likert-type scale. Therefore, a 5-point rating scale was used (1=never, 
2=almost never, 3=sometimes, 4=almost always, and 5=always), which was shown to be 
more easily understood. The total subscale score was obtained by the sum of the item 
scores, with higher scores indicating greater use of the specific coping strategy.  
 
2.2.1.6. Life Orientation Test – revised (LOT-R) [93]: evaluated the personality trait 
optimism using 8 items. The total score ranges from 0 to 12 (α=0.95), with high values 
associated with more optimism. 
 
2.2.2. Post-surgical assessment – 48 hours after surgery (T2) 
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Forty-eight hours after surgery, women were again assessed in a face-to-face interview by 
the same Psychologist who performed the baseline assessment in T1.  
2.2.2.1. Acute post-surgical pain measurement 
Worst and average level of acute pain intensity, within the first 48 hours after surgery, 
were assessed using an 11-point numerical rating scale (NRS from the BPI-SF described 
above) [24].  
The post-surgical pain frequency assessment was performed using the frequency scale of 
the McGill Pain Questionnaire [67]. Pain could be defined either as constant (continuous, 
steady), intermittent (periodic, rhythmic) or brief (momentary, transient).  
2.2.2.2. Post-surgical anxiety  
Post-surgical anxiety was evaluated again at this time point using the HADS anxiety 
subscale [112] already described.  
 
2.2.3. Post-surgical assessment – 4 months (T3) and 5 years after surgery (T4) 
Four months and 5 years after surgery, telephone calls were made to every participant in 
order to check for the presence of pain. The question was: “Do you still have any pain that 
you could link to surgery or that you could relate to the surgical procedure?”. This is an 
adaptation of the BPI-SF first question on pain prospection. If women answered no, those 
women were classified as cases without pain. Contrarily, if women answered yes, they 
were considered pain cases. For those women reporting pain, additional measures were 
employed, which focused on pain assessment: 
2.2.3.1. The Brief Pain Inventory – short form (BPI-SF) [24]: as described above. 
2.2.3.2. Pain frequency description: pain frequency could be described as constant, daily, 
several times a week but not daily, several times a month but not weekly, during sexual 
intercourse, by touch or lifting weight.  
2.2.3.3. Neuropathic Pain Questionnaire (DN-4) [4]: previous research described CPSP as 
a potential neuropathic pain [49,52]. This instrument assesses pain characteristics/quality 
using 10 items. Seven of them refer to specific pain sensory descriptors, such as burning, 
pinpricking or numbness, and patients answer if their pain has those characteristics using 
9 
 
a dichotomous response format (yes or no). The last three items result from the sensory 
examination of patients performed by a clinician. For the purpose of this study, only the 
first seven items were included [5]. Besides the information regarding pain quality, this 
questionnaire also provides information concerning the potential likelihood of 
neuropathic pain, corresponding to a cut-off of 3 (DN43).  
 
2.3. Surgical procedures, anesthetic and analgesic techniques 
Clinical data related to the surgery, anesthesia and analgesia was collected from medical 
records.  
Regarding surgical procedure, among the 170 women who underwent surgery, 122 
(71.8%) were submitted to total abdominal hysterectomy, 31 (18.2%) to vaginal 
hysterectomy, 11 (6.5%) to total laparoscopic hysterectomy and 6 (3.5%) to 
laparoscopically assisted vaginal hysterectomy. In abdominal hysterectomy (n=122), a 
Pfannenstiel incision was performed in 102 women (83.6%), being established as the first 
choice, with a vertical infra-umbilical incision being performed in 20 women (16.4%), 
corresponding to cases wherein a previous vertical surgical scar was present.  
Concomitant procedures, such as oophorectomy, ovarian cystectomy, salpingectomy, 
cystoscopy or vaginal repair, were also performed in a few patients. Moreover, uterus 
weight and height were also recorded.  
Concerning the type of anesthesia, 51 (30.0%) patients had general anesthesia, 22 (12.9%) 
had locoregional and 97 (57.1%) were submitted to combined anesthesia (general + 
locoregional). ASA score (physical status classification of the American Society of 
Anesthesiologists) was recorded, including cases of ASA grade I (49, 28.8%), II (107, 62.9%) 
and III (14, 8.2%).  
In what regards analgesic procedures, a post-surgical 48 hours standardized analgesia 
protocol was assigned to all patients. This protocol was established and supervised by the 
Acute Pain Service, prior to the transferring of patients to the infirmary.  
Delivery of the analgesic protocol was either epidural or intravenous. The standardized 
epidural protocols could be: a) a continuous epidural infusion (DIB - delivered infusion 
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balloon) with ropivacaine (0.1%) and fentanyl (3ug/ml), administrated to 105 (61.8%) 
women; or b) administration of an epidural morphine bolus (2-3 mg, 12/12h), assigned to 
14 (8.2%) women. The intravenous protocol consisted in a continuous intravenous 
infusion (DIB) of tramadol (600 mg), metamizol (6 gr) and metoclopramide (60 mg) and 
was used with 51 (30.0%) patients.  
Paracetamol (1 gr 6/6h) and non-steroidal anti-inflammatory drugs (NSAIDs - ketorolac 30 
mg 12/12h or parecoxib 40 mg 12/12h) were always included as coadjuvant analgesics. In 
addition, all analgesic regimens included prokinetic treatment that was standardized to 
metoclopramide (10 mg i.v. 8/8h). In cases of moderate or severe acute post-surgical pain 
levels (numerical rating scale, NRS>3) rescue analgesia was prescribed beyond the 
standardized analgesic protocol. Due to the great variability in analgesics’ protocol and 
dosages, no attempt was made to determine total equianalgesic medication dosages. 
Instead, it was recorded whether rescue analgesics were given to patients or not.  
The use of psychotropic drugs (anxiolytics and anti-depressants) during hospital stay was 
detailed from hospital records.  
 
2.4. Statistical Analyses 
The primary outcome variable under study is post-surgical pain trajectory, corresponding 
to three possible pain trajectory groups: (1) No CPSP or Pain Trajectory 1 (PT1), comprised 
by women who did not report pain neither at 4 months nor at 5 years after surgery; (2) 
Prolonged PSP or Pain Trajectory 2 (PT2), including women who complained of pain 4 
months after surgery, but not 5 years after; and (3) CPSP or Pain Trajectory 3 (PT3), 
comprising those women who reported pain both at 4 months and 5 years after 
hysterectomy. These groups were defined taking into account pain report [yes (presence) 
or no (absence)] 4 months and 5 years after hysterectomy (T3 and T4). 
To compare the three groups on the variables under analysis, Chi-square or Fisher tests 
and One-way ANOVA statistical tests were computed. For the latter, in the case of 
significant results (p < 0.05), Bonferroni post-hoc tests were performed in order to further 
investigate between-group differences. These preliminary analyses were exploratory, and 
11 
 
were performed to determine the predictor variables to include in the subsequent 
regression analyses.  
Finally, a set of predictive multinomial logistic regression models were conducted to 
investigate risk factors associated with pain trajectory group membership. The socio-
demographic, clinical and psychological variables selected for the regression analyses 
were those that distinguished pain trajectory groups in univariate analyses. Two structural 
models were developed: Model 1 (M1), investigating the role of baseline pre-surgical 
variables (T1), allowing for the establishment of a pre-surgical risk profile; and Model 2 
(M2), aiming at further understanding the role of acute post-surgical factors, 48 hours 
after hysterectomy (T2). These basic structural models, include demographic (age) and 
clinical [pain-related (pre-surgical pain) and surgery-related (type of hysterectomy)] 
variables that significantly distinguished the groups in univariate analyses, in order to 
control these effects in group comparisons. 
Considering the role of pre-surgical baseline predictors, and due to shared variance among 
the five psychological predictors (and consequent multicollinearity), which emerged as 
significant in the distinction of the three groups, three different sub-models were 
considered. The first model (M1A) focused on emotional variables (pre-surgical anxiety 
and fear), the second (M1B) centered on illness perceptions (emotional representation of 
the disease underlying surgery) and the third model (M1C) tested the role of pain coping 
strategies (pain catastrophizing).  
Regarding acute post-surgical factors, two models were computed, both controlling for 
the same abovementioned demographic and clinical variables that were controlled for in 
pre-surgical models. Beyond these covariates, the first model (M2A) tested for the specific 
predictive role of acute post-surgical pain intensity and frequency. The second post-
surgical model (M2B) was akin to the first though it had the addition of post-surgical 
anxiety.  
Data were analyzed using the IBM SPSS Statistics version 24.0. Internal consistency of 
responses to the questionnaires was assessed using Cronbach’s alpha [27]. Results were 
considered significant for p-values < 0.05. Effect size measures were interpreted 
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considering the Cohen’s [25] rule of thumb for eta squared (2): small effect size=0.02; 
medium effect size=0.13; large effect size=0.26; and Rea & Parker [85] for Cramer’s Phi () 
or Cramer’s V for nominal data: negligible association: 0 and under 0.10; weak association: 
0.10 and under 0.20; moderate association: 0.20 and under 0.40; relatively strong 
association: 0.40 and under 0.60; strong association: 0.60 and under 0.80; very strong 
association: 0.80 and under 1.00. 
 
3. RESULTS  
 
3.1. Pain Trajectory (PT) according to pain report 4 months (T3) and 5 years (T4) after 
hysterectomy   
Table 1 presents the number of women within each pain trajectory group, according to 
the course of pain up to five years after surgery.  
Considering Pain Trajectory, 88 (51.8%, PT1) women did not complain of pain at 4 months 
or 5 years after surgery. This was the largest group and was called “No Chronic Post-
Surgical Pain”. This pain trajectory is a typical, expected and desirable one in terms of 
healing and normal recovery. The second group was comprised of 53 (31.2%, PT2) women 
who complained of pain 4 months post-surgery, but at 5 years after surgery did not 
experience any related pain. This group was labelled “Prolonged Post-Surgical Pain”. The 
third Pain Trajectory group (PT3) included 29 (17.1%) women who reported pain both at 4 
months and 5 years following hysterectomy. As their pain persisted over time, this group 
was labelled “Chronic Post-Surgical Pain”. All patients reporting pain at the 5-year follow-
up also had reported pain at 4 months post-surgery. Patients not reporting pain at the 4-
months follow-up also did not report pain 5 years later. Thus, there were no cases of “new 
pain” with a later onset beyond the 4-month follow-up timepoint. 
 
3.2. Differences among Pain Trajectory (PT) groups on socio-demographic, clinical and 
psychological variables  
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Table 2 shows that before surgery, PT groups differed in age [p=.013; 2 =.051, small 
effect size (ES)], with PT1 being older than PT2 (p=0.003). Concerning clinical measures, 
the groups were similar in terms of surgical disease onset, BMI (body mass index), 
previous surgical procedures or pre-surgical psychotropic use. Regarding pre-surgical pain, 
the three groups of women differed significantly on pre-surgical pain related to the 
condition underlying surgery (p=0.032;  =.201, moderate association), but not on 
previous chronic pain due to other causes (see Table 2). Among the 3 empirically derived 
pain trajectory groups, and regarding psychological variables measured before surgery, 
there were significant differences in anxiety (p<0.001; 2 =.094, small ES), surgical fear 
related to long-term consequences of surgery (p=0.022; 2 =.045, small ES), emotional 
representation of surgical disease (p=0.001; 2 =.081, small ES) and pain catastrophizing 
(p<0.001; 2 =.090, small ES).  For all these variables, higher values were associated with 
chronic pain groups membership in PT2 or PT3. 
In terms of surgery, the PT groups could be distinguished based on the type of surgical 
approach (p=0.007;  = .242, moderate association) and among those undergoing 
abdominal hysterectomy there were also differences across groups on the type of 
abdominal incision (p=0.003;  =.260, moderate association). The PT2 and PT3 groups had 
more women undergoing abdominal hysterectomy and a pfannenstiel incision. 
In the acute post-surgical period, 48 hours after surgery, the three PT groups of women 
showed differences in acute pain report, regarding worst (p<0.001; 2 =.096, small ES) and 
average (p=0.001; 2 =.086, small ES) pain intensity, pain frequency (p=0.001;  =.286, 
moderate association) and post-surgical anxiety (p<0.001; 2 =.109, small ES). These 
differences showed that the PT2 and PT3 groups scored more negatively on these 
variables. 
 
3.3. Pain incidence, characteristics and perceived impact 5 years after hysterectomy  
Among the 170 women who completed the four assessments, 29 (17.1%) revealed an 
unfavorable pain trajectory after hysterectomy, reporting pain both at 4 months and 5 
years after surgery, therefore being considered CPSP cases (Table 3). From these 29 cases 
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of CPSP, Table 3 highlights that in terms of pain frequency, the majority of women (44.8%) 
reported pain several times a week, with 24.2% of women perceiving pain on a daily basis 
and 20.7% complaining of pain only during sexual intercourse or by touch. Additionally, 
the mean of worst pain intensity was 3.17 (SD=1.61) and the mean average level of pain 
intensity was 1.89 (SD=0.88), on the 0-10 NRS. It was also shown that 34.5% of CPSP 
women rated their worst pain intensity above 3 (NRS>3), indicating moderate and/or 
severe pain levels. Table 3 also reveals that the pain sensory characteristics more often 
described by CPSP patients were feeling of pins and needles (51.7%) and numbness 
(31.0%). In terms of a potential neuropathic pain component of CPSP, five (17.2%) women 
presented a DN4 ≥ 3 value. Pain interference was reported in all domains, the most 
common being mood (57.1%), enjoyment of life (50.0%), general activity (42.9%), normal 
work (42.9%) and walking ability (28.6%). Nevertheless, mean values of pain interference 
were in the low to medium range.  
 
3.4. Predictors of Post-Surgical Pain Trajectory  
In order to identify the pre-surgical predictors of an unfavorable pain trajectory, three 
multinomial regression models were computed (Table 4), controlling for the demographic 
and clinical variables that distinguished the three groups: age, previous surgical pain, and 
type of hysterectomy. The first Model (M1A) further tested for the influence of 
psychological factors related to emotional distress, namely pre-surgical anxiety and 
surgical fear related to the long-term consequences of surgery. Table 4 shows that pre-
surgical anxiety is a predictor of pain trajectory, being a determinant of group 
membership, with higher anxiety scores being associated with both the “Prolonged PSP 
group” (PT2; OR = 1.131, p = 0.015; for each unit increased in pre-surgical anxiety, the 
odds of being in the PT2 group is 1.131 times higher than those of being in the PT1 group) 
and the “CPSP group” (PT3; OR = 1.175, p = 0.009), when compared with the “No CPSP 
group” (PT1). All other variables were not significant. Table 4 also reveals results on the 
influence of psychological factors associated with illness perceptions (M1B) and pain 
coping strategies (M1C). Within M1B, emotional representation of the condition 
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underlying surgery emerged as the only factor significantly associated with group 
membership, with high scores predicting PT2 (OR = 1.165, p = 0.018) and PT3 (OR = 1.246, 
p = 0.005) membership. Within M1C, pain catastrophizing was the only variable yielding a 
significant association with either membership in PT2 (OR = 1.079, p = 0.043) or PT3 (OR = 
1.143, p = 0.001) groups. Concerning factors that could distinguish PT2 from PT3 
membership, Table 4 indicates that the psychological construct fear of long-term 
consequences of surgery was the only significant predictor (OR = 1.078, p = 0.049). 
In order to further explore the role of acute post-surgical variables in the development of 
an unfavorable pain trajectory, over and above demographic and clinical factors, two 
subsequent models were tested (see Table 5). The first model (M2A) revealed that acute 
post-surgical pain intensity and frequency determined inclusion of women in PT3 (OR = 
1.211, p = 0.033 and OR = 3.000, p = 0.029, respectively). The second post-surgical model 
(Model 2B) added post-surgical anxiety to the variables of the previous model in order to 
test its predictive role. Subsequently, both acute post-surgical pain intensity and 
frequency ceased to be significant and post-surgical anxiety became the only variable 
predicting PT3 (CPSP) (OR = 1.182, p = 0.026). Age, previous pain and type of 
hysterectomy did not contribute to the prediction of an unfavorable pain trajectory in any 
of the models (see Tables 4 and 5).  
 
4. DISCUSSION  
 
This prospective cohort study followed women up to five years after hysterectomy and 
found that pre-surgical anxiety, emotional illness representations and pain catastrophizing 
were risk factors for post-surgical pain. Higher post-surgical anxiety, acute pain intensity 
and frequency increased the likelihood of a worst pain trajectory. These results are novel 
since there are no prospective studies on chronic post-surgical pain (CPSP) after 
hysterectomy with such a long follow-up and that consider the trajectory of pain over two 
long-term follow-up times (4 months and 5 years post-hysterectomy). This study also adds 
to previous findings regarding pain at 48 hours [76,77] and 4 months [80] post-surgery.     
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4.1. CPSP Prevalence after Hysterectomy 
Almost half of women (48.2%) reported pain 4 months after hysterectomy. Five years 
later, 17.1% still complained of pain. Within hysterectomy studies, the longest follow-up 
period we are aware of (2 years), revealed a CPSP prevalence of 24.1% and 16% in 
abdominal and vaginal hysterectomy, respectively [68]. With a 1 year follow-up, 
Theunissen et al [101] reported a prevalence of 9%, though the criteria underlying CPSP 
definition was a cut-off level of 3 (NRS>3), indicative of moderate or severe pain intensity. 
A retrospective study [7] reported 31.9% prevalence and in a prospective study [6], 4 
months post-surgery and using a different CPSP definition (pain with impact on daily 
living), the prevalence rate was 16.7%. Two other studies described a prevalence of 14% 
[104] and 26% [81], 6 months post-hysterectomy.  
These figures clearly reveal large discrepancies in CPSP report, most likely due to the 
diverse range of follow-up times and CPSP definitions [49,70]. The relatively higher 
prevalence of CPSP found in our study may be due to not having included only those 
women reporting moderate to severe pain (NRS>3). On the other hand, our findings show 
that pain only interfered with the lives of some women and that interference was in the 
low to medium range.  
 
4.2. Predictors of CPSP after Hysterectomy 
 
4.2.1. Demographic and Clinical Factors  
In contrast to earlier findings [6,7,68,80,98,101,104], age and pre-surgical pain did not 
predict CPSP. Studies that found such relationships had shorter follow-ups, from 4 months 
to 2 years. Consistent with previous results [3,6,7,98,101,104], hysterectomy type did not 
predict CPSP albeit this does not support our earlier findings [80], nor Montes et al [68] 
conclusions. These results were unexpected and suggest that the strength of association 
of demographic and clinical factors probably diminishes with time, as psychological factors 
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play an increasingly greater role. A similar conclusion was drawn previously in a post-
mastectomy study with a 3-year follow-up [2]. 
Acute post-surgical pain intensity is a well-established key predictive factor 
[13,14,53,56,62,63], including in hysterectomy CPSP studies [6,81,98,101,104]. Present 
results support this and further add post-surgical pain frequency, as previously found in 
this sample [77]. To our knowledge, only Fletcher et al [35] found pain frequency to be a 
CPSP predictor. These results highlight pain frequency as a new potential target in CPSP 
prevention. When adding post-surgical anxiety to the equation, both acute pain predictors 
ceased to be significant, which indicates both their shared variance and the unique 
contribution of post-surgical anxiety in the prediction of CPSP.  
It is noteworthy that the acute post-surgical variables only predicted pain five years later. 
This suggests that to prevent long-term post-hysterectomy pain, women should be 
screened and targeted throughout the perioperative period, and not only before surgery. 
Baseline assessments are useful for medium and long-term pain prediction whereas acute 
post-surgical variables seem to better predict long-term chronic pain. 
 
4.2.2. The key Role of Psychological Predictors  
Pre-surgical anxiety and pain catastrophizing were predictive of an unfavorable post-
surgical pain trajectory and CPSP, which corroborates previous findings [16,44,100]. Pre-
surgical anxiety, already shown to be a predictor of CPSP 4 and 6 months [80,104] post-
hysterectomy, is also predictive of CPSP 5 years later. Furthermore, pain catastrophizing, a 
well-established CPSP psychological risk factor [2,15,51,57,84], appears as a predictor for 
the first time in our hysterectomy studies [80].  
Our results also confirm the important role of emotional representation of the surgical 
disease and of post-surgical anxiety [80]. Other studies have demonstrated the impact of 
cognitive and affective responses triggered by illness on health outcomes [58,92], 
although the investigation of their predictive role on post-surgical pain has been scarce 
[78,80]. Post-surgical anxiety is such a response, present findings highlighting the need to 
address anxiety throughout the perioperative period, and not only before surgery.  
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While all baseline psychological factors are common predictive factors for both PT2 and 
PT3 membership, pre-surgical fear of long-term consequences of surgery was the only 
variable specifically distinguishing these groups. Hence, presenting higher levels of fear 
related with long-term issues, such as fear of health deterioration or long-lasting surgical 
recovery, appears to confer a greater risk of long-lasting pain.  
The set of predictive models used in this study, which include pre- and perioperative 
emotion and cognitions, seem to reveal a psychological vulnerability profile, influencing 
post-surgical pain trajectory and ultimately the development of CPSP. This critical role of 
psychological factors on pain experience helps to understand the discrepancy that 
sometimes emerges between physical pathology, injury and pain report [16,56,87,109]. 
These findings are also in accordance with the gate control and neuromatrix theories of 
pain [65,66], as well as with the biopsychosocial approach to pain [37], which recognize 
pain as a multidimensional subjective experience.   
Peripheral sensitization, central sensitization and descending modulation constitute three 
interweaved processes believed to underlie CPSP [63]. Augmented activation of pain 
pathways may stem from peripheral and/or central sensitization, though pain 
amplification may also arise from abnormalities in descending modulatory systems 
[73,82,111]. These descending pathways involve endogenous opioids, serotonin and 
noradrenaline, presenting both excitatory and inhibitory actions on spinal cord afferent 
projection neurons and could be activated by psychological factors [11]. Catastrophizing, 
anxiety, and other negative emotions are associated with reduced effectiveness in 
descending pain-inhibitory systems [84,106], facilitating spinal nociception and pain, 
whereas positive affect and self-regulatory skills inhibit spinal nociception and pain 
[28,39,89-91]. The primary role of catastrophizing in pain modulation has been highlighted 
[16,18,34,39,51,95] and suggested to be associated with diminished endogenous 
inhibition of pain coupled with central sensitization [84]. Moreover, an association was 
shown between adaptive pain coping strategies and activation of descending endogenous 
opioid systems [1] and between depressed mood and impaired endogenous inhibition of 
pain [30].  
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4.3. Practical and Clinical implications 
Since chronic pain is very difficult to treat, the importance of secondary prevention is 
highlighted [38,94]. Besides, and despite the enthusiastic and promising findings of some 
trials focusing on preventive analgesic approaches [10,12,21,29,75,97], there is not yet 
any robust evidence to support the unequivocal efficacy of systemic drugs for CPSP 
prevention [9,17,19,43,54,61,64,87]. Moreover, notwithstanding the advances in 
knowledge about pain genetics [22,31,32,71,72], there is not, until now, sustained 
evidence for genetic predisposition for CPSP development [22,49,68,87] that could assist 
in screening for pain-prone patients and in informing a personalized pain treatment 
protocol. This leaves room for the implementation of psychological interventions aimed at 
preventing CPSP [15,23,33,48-50,63,100]. Indeed, present findings point to CPSP 
predictors that are modifiable risk factors, amenable to change or to active management, 
precisely through psychological interventions. Targeting them might yield adaptive and 
functional changes in brain pain processing, thus being an effective way to prevent CPSP 
development [34,95]. 
The effectiveness of psychological interventions in pain is well established [36,46], though 
in the surgical field it is overdue [15,48,56]. As substantial advances are being made in 
identifying risk factors for CPSP, the design and testing of preventive pain-management 
strategies stemming from this evidence is warranted as well as the analysis of their cost-
effectiveness. An enthusiastic and promising novelty in this field is the development and 
implementation of a Transitional Pain Service, a multidisciplinary program aimed at 
preventing and managing CPSP, which offers simultaneous psychological and 
pharmacological interventions [20,23,42,50]. 
Psychological interventions have the power to impact supraspinal mechanisms involving 
higher pain centers [63], influencing endogenous modulation of pain, thereby improving 
endogenous analgesia, similarly to mechanisms underlying pharmacological analgesia 
[34,45,46,84]. For example, cognitive-behavioral therapy has been related to changes in 
brain limbic activity, which have been implicated in improvement of anxiety and 
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potentiation of descending modulatory inhibition of pain [55,108]. Increased grey matter 
in prefrontal and parietal brain regions linked with chronic pain, was also observed 
following cognitive-behavioral therapy, being associated with a decrease in pain 
catastrophizing [96].  
 
4.4. Limitations and Strengths  
This is a single-site and single-country study, which compromises its external validity, thus 
limiting the generalization of results. Sample attrition is a potential limitation, stemming 
from the longitudinal design, although our study showed high retention over time. Other 
potential limitation is the absence of a physical examination at T3 and T4, screening for 
inflammation or nerve injury.  
The breath of pre-surgical measures, embracing demographic, clinical and a thorough 
range of psychological variables was a strength, along with the long-term follow-up of 5 
years.  
 
4.5. Conclusion 
This study identified risk factors that can be easily screened before and after surgery, and 
are amenable to intervention. The design of timely and tailored interventions for women 
at risk of an unfavorable post-surgical pain trajectory after hysterectomy is a key priority. 
Incorporating risk-targeted multidisciplinary and feasible interventions focused on CPSP 
prevention into surgical routine practice is an important challenge that is likely to 
contribute to the improvement of pain management and patient care throughout the 
process of surgery. 
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Figure 1: Flowchart of Women undergoing Hysterectomy  
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Table 1 
Pain trajectory groups according to pain report at 4 months (T3) and 5 years (T4) after hysterectomy 
Pain Trajectories CHRONIC PAIN REPORT (N=170)  Group Designation 
 
T3 
(4 Months after surgery) 
T4 
(5 Years after surgery) 
n (%)  
Pain Trajectory 1 (PT1)  NO NO 88 (51.8%) No Chronic Post-Surgical Pain  
Pain Trajectory 2 (PT2) YES NO 53 (31.2%) Prolonged Post-Surgical Pain 
Pain Trajectory 3 (PT3) YES YES 29 (17.1%) Chronic Post-Surgical Pain 
 
Table 2 
Differences between pain trajectory groups on socio-demographic, clinical and psychological variables measured 24 hours 
before (T1) and 48 hours after Hysterectomy (T2) 
MEASURES 
Pain 
Trajectory 1 
(PT1) 
(n = 88) 
Pain 
Trajectory 2 
(PT2) 
(n= 53) 
Pain 
Trajectory 3 
(PT3) 
(n= 29) 
F / 2 
 
p 2 /  
Pre-surgical data 24H before surgery-T1       
SOCIO-DEMOGRAPHIC: Age [years(SD)] 52.8 (10.2)a 48.7 (6.43)b 48.7 (8.19)ab 4.446 0.013 0.051 
PRE-SURGICAL CLINICAL VARIABLES       
Disease onset (months) 39.2 (48.6) 36.3 (46.0) 44.9 (71.4) 0.250 0.779 0.003 
BMI1 (Kg/m2) 28.8 (4.26) 29.0 (4.78) 27.9 (4.15) 0.585 0.558 0.007 
Previous surgeries (yes) 62 (70.5%) 37 (69.8%) 21 (72.4%) 0.063 0.969 0.019 
Psychotropic use2 (yes) 28 (33.7%) 19 (37.3%) 14 (48.3%) 1.941 0.379 0.109 
Pre-surgical pain (yes) 44 (50.0%) 36 (67.9%) 21 (72.4%) 6.858 0.032 0.201 
Previous pain due to other causes3 (yes) 49 (55.7%) 37 (69.8%) 21 (72.4%) 4.176 0.124 0.157 
PSYCHOLOGICAL VARIABLES (Range)       
HADS4: Anxiety (0-21) 6.02 (3.84)b 7.87 (3.96)a 9.38 (4.81)a 8.615 <0.001 0.094 
HADS4: Depression (0-21) 1.89 (2.48) 2.68 (3.71) 2.69 (2.93) 1.509 0.224 0.018 
SFQ5: Immediate consequences (0-40) 9.02 (8.55) 10.8 (7.26) 13.3 (10.1) 2.892 0.058 0.033 
SFQ5: Long-term consequences (0-40) 4.61 (6.78)b 4.66 (5.33)b 8.41 (8.12)a 3.929 0.022 0.045 
IPQ-R6: Timeline acute/chronic (3-15) 6.11 (1.39) 5.98 (1.01) 6.52 (1.53) 1.607 0.204 0.019 
IPQ-R6: Timeline cyclical (3-15) 6.94 (3.09) 7.85 (3.20) 8.28 (3.36) 2.530 0.083 0.029 
IPQ-R6: Treatment control (3-15) 12.2 (0.98) 12.2 (0.77) 12.1 (0.75) 0.231 0.794 0.003 
IPQ-R6: Illness coherence (3-15) 9.27 (2.76) 9.36 (2.60) 9.90 (2.58) 0.604 0.548 0.007 
IPQ-R6: Emotional representation (3-15) 7.60 (2.89)b 9.04 (2.90)a 9.62 (2.68)a 7.383 0.001 0.081 
CSQ-R7: Pain catastrophizing (6-30) 9.25 (4.28)b 11.3 (5.81)ab 13.6 (6.50)a 8.232 <0.001 0.090 
CSQ-R7: Praying /Hoping (3-15) 9.57 (4.22) 10.0 (4.04) 10.5 (3.67) 0.560 0.573 0.007 
CSQ-R7: Ignoring (5-25) 12.4 (5.81) 11.9 (6.18) 11.0 (6.12) 0.568 0.568 0.007 
CSQ-R7: Diverting attention (5-25) 9.70 (4.70) 10.2 (4.54) 9.86 (4.76) 0.213 0.808 0.003 
CSQ-R7: Reinterpreting pain (4-20) 6.71 (3.23) 7.00 (3.52) 6.96 (3.88) 0.133 0.876 0.002 
CSQ-R7: Pain coping self-stat (4-20) 16.0 (3.61) 15.9 (3.53) 14.9 (3.57) 1.092 0.338 0.014 
LOT-R8: Optimism (0-12) 7.30 (3.48) 6.63 (3.01) 7.14 (3.25) 0.663 0.517 0.008 
POST-SURGICAL VARIABLES       
Type hyst9: open abdominal 54 (61.4%) 43 (81.1%) 25 (86.2%) 9.978 0.007 0.242 
Abdom. Incis.10: Pfannenstiel 42 (47.7%) 39 (73.6%) 21 (72.4%) 11.460 0.003 0.260 
Uterus weight (gr) 219 (220) 217 (207) 205 (213) 0.045 0.956 0.001 
Uterus height (cm) 9.61 (2.65) 9.30 (2.70) 9.49 (2.62) 0.228 0.797 0.003 
Worst pain intensity11 4.40 (2.85)b 5.70 (2.79)a 6.86 (3.03)a 8.853 <0.001 0.096 
Average pain intensity11 2.59 (1.61)b 3.55 (1.58)a 3.55 (1.43)a 7.901 0.001 0.086 
Pain Frequency12: constant 17 (19.3%) 18 (34.0%) 16 (55.2%) 13.928 0.001 0.286 
HADS4: Anxiety  2.05 (2.50)b 3.23 (3.83)b 5.21 (4.36)a 10.18 <0.001 0.109 
Psychotropic use2 (yes) 33 (37.5%) 21 (39.6%) 14 (50%) 1.392 0.498 0.091 
Length of stay (days) 3.10 (0.94) 3.00 (0.56) 3.00 (0.48) 0.373 0.689 0.005 
Note: Continuous variables are presented as Mean (Standard deviation); Categorical variables are presented as n (%);1BMI = body 
mass index; 2Psychotropic use: Consumption / Intake of anxiolytics and anti-depressants; 3Other previous chronic pain states not 
related to the cause of surgery; 4HADS = Hospital Anxiety and Depression Scale; 5SFQ = Surgical Fear Questionnaire; 6IPQ-R= Illness 
Perception Questionnaire-Revised; 7CSQ-R=Coping Strategies Questionnaire-Revised; 8LOT-R = Life Orientation Test – revised; 
9Type of hysterectomy: n(%) of open abdominal hysterectomies vs abdominal laparoscopic, vaginal and vaginal assisted 
laparoscopic; 10Abdominal incision: n(%) of pfannenstiel incisions vs infraumbilical vertical incision and laparoscopies; 
11NRS=Numerical Rating Scale 0-10 from Brief Pain Inventory (BPI); 12Pain Frequency: constant pain vs intermittent or brief pain, 
assessed via frequency subscale of McGill Pain Questionnaire. 
abc: Different letters represent p-values < 0.05 in ANOVA post-hoc tests; for example, in age groups comparisons PT1 (represented 
with a) is significantly different from PT2 (represented with b) and PT3 does not significantly differ from PT1 and PT2 (represented 
with ab).   
Table 3 – Incidence, characteristics and impact of pain 5 years after Hysterectomy (N=29) 
 
Pain 5 years after Hysterectomy – T4 N (%) M (SD) Min-Max 
Pain Report - CPSP1 29 (17.1%)   
Frequency      
   Daily 7 (24.2%)   
   Several times a week but not daily 13 (44.8%)   
   Several times a month but not weekly 3 (10.3%)   
   During sexual intercourse / by touch 6 (20.7%)   
Intensity2 (NRS 0-10)    
   Worst level   3.17 (1.61) 1 - 7 
      NRS>3 10 (34.5%)   
   Average level   1.89 (0.88) 1 - 4 
      NRS>3 1 (3.4%)   
DN-43 (Could report one or more)    
   Pins and Needles 15 (51.7%)   
   Numbness 9 (31.0%)   
   Itching 6 (20.7%)   
   Tingling 3 (10.3%)   
   Burning 2 (6.9%)   
   Painful cold  1 (3.4%)   
   Electric shocks 1 (3.4%)   
      DN4<3 23 (82.8%)   
      DN43 5 (17.2%)   
Pain Interference4 (NRS 0-10)    
   General activity 12 (42.9%) 1.07 (1.41) 0 - 4 
   Mood 16 (57.1%) 1.64 (1.83) 0 - 5 
   Walking Ability 8 (28.6%) 0.57 (1.03) 0 – 3 
   Normal Work 12 (42.9%) 1.14 (1.56) 0 – 5 
   Relations with other people 5 (17.8%) 0.32 (0.77) 0 – 3 
   Sleep 2 (7.2%) 1.79 (0.67) 0 – 3 
   Enjoyment of life 14 (50%) 1.32 (1.68) 0 - 5 
 
Note: Continuous variables are presented as mean (standard deviation); categorical variables are presented as n (%); 1Women reporting 
CPSP - chronic post-surgical pain 5 years after hysterectomy; 2NRS: Numerical Rating Scale (0 - 10); 3DN-4: Neuropathic Pain Questionnaire; 
4Items from BPI-SF: Brief Pain Inventory – short form.  
 
Table 4 
Multinomial logistic regression model relating Pain Trajectory Membership with pre-surgical variables 
measured 24 hours before Hysterectomy 
       95% CI 
Pain Trajectory 
Comparison 
PRE-SURGICAL MODELS 
Nagelkerke 
R2 
B SE Wald OR LL UL 
 
MODEL 1A – Emotional 
Distress 
0.206       
PT1 VS PT2 Age1  -0.036 0.024 2.334 0.964 0.920 1.010 
 Pre-surgical pain2  0.231 0.416 0.309 1.260 0.557 2.851 
 Type of Hysterectomy3  0.750 0.447 2.820 2.118 0.882 5.084 
 Pre-surgical anxietya  0.123 0.051 5.924* 1.131 1.024 1.249 
 Pre-surgical fearb  -0.044 0.034 1.677 0.957 0.895 1.023 
PT1 VS PT3 Age1  -0.013 0.032 0.157 0.987 0.927 1.052 
 Pre-surgical pain2  0.706 0.534 1.752 2.026 0.712 5.767 
 Type of Hysterectomy3  1.010 0.621 2.650 2.747 0.814 9.273 
 Pre-surgical anxietya  0.161 0.062 6.799** 1.175 1.041 1.326 
 Pre-surgical fearb  0.031 0.035 0.802 1.032 0.964 1.104 
PT2 VS PT3 Age1  0.024 0.034 0.471 1.024 0.957 1.095 
 Pre-surgical pain2  0.475 0.557 0.726 1.608 0.540 4.790 
 Type of Hysterectomy3  0.260 0.669 0.151 1.297 0.350 4.809 
 Pre-surgical anxietya  0.038 0.062 0.376 1.039 0.920 1.173 
 Pre-surgical fearb  0.075 0.038 3.880* 1.078 1.000 1.162 
 
MODEL 1Ba - Illness 
Perceptions 
0.171    
 
  
PT1 VS PT2 Age1  -0.030 0.023 1.697 0.970 0.928 1.015 
 Pre-surgical pain2  0.263 0.405 0.423 1.301 0.588 2.878 
 Type of Hysterectomy3  0.793 0.445 3.168 2.209 0.923 5.290 
 
Emotional 
representationc 
 0.152 0.064 5.586* 1.165 1.026 1.321 
PT1 VS PT3 Age1  -0.018 0.030 0.378 0.982 0.926 1.041 
 Pre-surgical pain2  0.430 0.515 0.698 1.538 0.560 4.219 
 Type of Hysterectomy3  1.166 0.621 3.530 3.209 0.951 10.829 
 
Emotional 
representationc 
 0.220 0.079 7.821** 1.246 1.068 1.455 
 
MODEL 1Ca – Pain 
Coping Strategies 
0.178       
PT1 VS PT2 Age1  -0.037 0.023 2.611 0.963 0.921 1.008 
 Pre-surgical pain2  0.373 0.402 0.862 1.452 0.661 3.190 
 Type of Hysterectomy3  0.609 0.045 1.878 1.839 0.769 4.395 
 Pain catastrophizingd  0.076 0.038 4.086* 1.079 1.002 1.162 
PT1 VS PT3 Age1  -0.034 0.031 1.172 0.967 0.910 1.028 
 Pre-surgical pain2  0.577 0.520 1.231 1.781 0.642 4.940 
 Type of Hysterectomy3  0.798 0.623 1.641 2.221 0.655 7.532 
 Pain catastrophizingd  0.134 0.042 10.170*** 1.143 1.053 1.241 
*p<0.05; **p<0.01; ***p<0.001 
 
Note: PT1: Pain Trajectory Group 1 (No Chronic Post-Surgical Pain); PT2: Pain Trajectory Group 2 (Prolonged Post-Surgical Pain); PT3: 
Pain Trajectory Group 3 (Chronic Post-Surgical Pain). 1Continuous variable, in years; 2Dichotomous variable: 0= No, 1= Yes; 
3Dichotomous variable:  0= abdominal laparoscopic, vaginal and vaginal assisted laparoscopic; 1= open abdominal hysterectomies; 
aContinuous variable, HADS-A: Hospital Anxiety and Depression Scale - anxiety subscale; bContinuous variable, Surgical Fear 
Questionnaire – fear of immediate consequences of surgery subscale; cContinuous variable, IPQ-R: Illness Perception Questionnaire 
Revised – all subscales; dCSQ-R: Coping Strategies Questionnaire Revised – all subscales. 
 
PT1 - Reference Group (In MODEL 1A PT2 VS PT3, PT2 is the reference group); OR - Odds Ratio; LL - Lower Limit; UL - Upper Limit. 
aFor models 1B and 1C, no significant predictors were found in the comparison of PT2 and PT3. 
 
 
Table 5 
Multinomial logistic regression model relating Pain Trajectory Membership with post-surgical variables 
measured 48 hours after Hysterectomy 
 
       95% CI 
Pain Trajectory 
Comparison 
POST-SURGICAL 
MODELS 
Nagelkerke 
R2 
B SE Wald OR LL UL 
 
MODEL 2Aa – Acute 
Pain  
0.192       
PT1 VS PT2 Age  -0.031 0.023 1.774 0.970 0.927 1.015 
 Pre-surgical pain2  0.289 0.404 0.511 1.335 0.605 2.946 
 Type of Hysterectomy3  0.640 0.443 2.083 1.896 0.795 4.552 
 
Acute post-surgical 
pain intensity4 
 0.067 0.069 0.957 1.070 0.935 1.224 
 
Acute post-surgical 
pain frequency5 
 0.429 0.431 0.992 1.535 0.660 3.571 
PT1 VS PT3 Age  -0.011 0.032 0.114 0.989 0.929 1.053 
 Pre-surgical pain2  0.388 0.527 0.543 1.474 0.525 4.139 
 Type of Hysterectomy3  0.765 0.634 1.457 2.149 0.620 7.441 
 
Acute post-surgical 
pain intensity4 
 0.191 0.090 4.525* 1.211 1.015 1.444 
 
Acute post-surgical 
pain frequency5 
 1.099 0.505 4.741* 3.000 1.116 8.065 
 
MODEL 2Ba – Acute 
Pain + Anxiety 
0.222       
PT1 VS PT2 Age1  -0.031 0.023 1.743 0.970 0.926 1.015 
 Pre-surgical pain2  0.360 0.410 0.771 1.433 0.642 3.201 
 Type of Hysterectomy3  0.637 0.446 2.041 1.890 0.789 4.527 
 
Acute post-surgical 
pain intensity4 
 0.031 0.074 0.172 1.031 0.892 1.192 
 
Acute post-surgical 
pain frequency5 
 0.306 0.445 0.474 1.358 0.568 3.250 
 Post-surgical anxietya  0.093 0.068 1.863 1.098 0.960 1.255 
PT1 VS PT3 Age1  -0.016 0.033 0.234 0.984 0.923 1.050 
 Pre-surgical pain2  0.430 0.536 0.643 1.537 0.538 4.391 
 Type of Hysterectomy3  0.715 0.646 1.224 2.044 0.576 7.255 
 
Acute post-surgical 
pain intensity4 
 0.123 0.097 1.620 1.131 0.936 1.367 
 
Acute post-surgical 
pain frequency5 
 0.786 0.536 2.152 2.195 0.768 6.277 
 Post-surgical anxietya  0.167 0.075 4.945* 1.182 1.020 1.370 
*p<0.05; **p<0.01; ***p<0.001 
 
Note: PT1: Pain Trajectory Group 1 (No Chronic Post-Surgical Pain); PT2: Pain Trajectory Group 2 (Prolonged Post-Surgical Pain); PT3: 
Pain Trajectory Group 3 (Chronic Post-Surgical Pain). 1Continuous variable, in years; 2Dichotomous variable: 0= No, 1= Yes; 
3Dichotomous variable:  0= abdominal laparoscopic, vaginal and vaginal assisted laparoscopic; 1= open abdominal hysterectomies; 
4Continuous variable, NRS 0-10 from BPI-SF: Brief Pain Inventory-Short Form; 5Dichotomous variable:  0= intermittent or brief pain, 
1=constant pain, frequency subscale of McGill Pain Questionnaire; aContinuous variable, HADS-A: Hospital Anxiety and Depression 
Scale - anxiety subscale;  
 
PT1 - Reference Group; OR - Odds Ratio; LL - Lower Limit; UL - Upper Limit. 
a For models 2A and 2B, no significant predictors were found in the comparison of PT2 and PT3.  
 
 
 
